WallStreetZenWallStreetZen

NASDAQ: TECH
Bio Techne Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bio Techne earnings were $73.4M for the trailing 12 months ending Jun 30, 2025, with -56.1% growth year over year. The latest TECH earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$17.7M, down 178.3% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, TECH reported annual earnings of $73.4M, with -56.3% growth. The next TECH earnings date is Nov 5, 2025.

TECH past earnings growth

How has TECH's earnings growth performed historically?

Company
-56.07%
Industry
30.11%
Market
34.43%
TECH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TECH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
TECH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

TECH earnings history

Current Revenue
$1.2B
Current Earnings
$73.4M
Current Profit Margin
6%
TECH's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

TECH Return on Equity

Current Company
3.6%
Current Industry
-10%
Current Market
30.7%
TECH's Return on Equity (3.6%)... subscribe to Premium to read more.
High Return on Equity Performance

TECH undefined

Current Company
2.8%
Current Industry
-0.2%
TECH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TECH announces earnings.

TECH undefined

Current Company
4.49%
Current Industry
6.4%
TECH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TECH vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TECH$216.88M$73.40M-20.71%$0.47
CORT$102.16M$131.98M+4.94%$1.26
JAZZ$371.29M-$404.84MN/A-$6.63
RVMD-$798.13M-$812.06MN/A-$4.51
HALO$791.84M$557.28M+28.37%$4.48
View Top Biotech Stocks

TECH earnings dates

Next earnings date
Nov 5, 2025

Bio Techne Earnings Reports & History FAQ

What were Bio Techne's earnings last quarter?

On TECH's earnings call on Invalid Date, Bio Techne (NASDAQ: TECH) reported Q2 2025 earnings per share (EPS) of -$0.11, up 142.31% year over year. Total TECH earnings for the quarter were -$17.68 million. In the same quarter last year, Bio Techne's earnings per share (EPS) was $0.26.

If you're new to stock investing, here's how to buy Bio Techne stock.

When does Bio Techne report earnings?

The next TECH earnings call is Invalid Date. Add TECH to your watchlist to be reminded of Bio Techne's next earnings date.

Is Bio Techne profitable or losing money?

As of the last Bio Techne earnings report, Bio Techne is currently profitable. Bio Techne's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $73.40 million, a 56.34% decrease year over year.

What was TECH's earnings growth in the past year?

As of Bio Techne's earnings date in Invalid Date, Bio Techne's earnings has grown -56.07% year over year. This is 86.19 percentage points lower than the US Biotechnology industry earnings growth rate of 30.11%. TECH earnings in the past year totalled $73.40 million.

What are Bio Techne's earnings expectations?

The current EPS estimate for Bio Techne's earnings report in Invalid Date is $0.43.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.